News Releases Keyword Search Year None2022202120202019201820172016 May-03-2021 Oncternal Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Apr-29-2021 Oncternal Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update Apr-28-2021 Oncternal Therapeutics Announces Presentation of Two Abstracts at ASCO 2021 Virtual Meeting Apr-12-2021 Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel Apr-12-2021 Oncternal Therapeutics Announces Presentation of Three Posters at AACR 2021 Virtual Meeting Mar-18-2021 Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Mar-11-2021 Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2020 Financial Results Mar-04-2021 Oncternal Therapeutics to Report Fourth Quarter 2020 Financial Results and Provide Business Update Feb-24-2021 Oncternal Therapeutics to Participate in March Investor Conferences Feb-22-2021 Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
